EscharEx versus placebo and non-surgical standard of care for venous leg ulcers

Phase 2, randomised trial in stasis ulcer comparing EscharEx, Placebo gel vehicle and Non-surgical standard of care (3 arms). Primary endpoints: Incidence and severity of systemic and local adverse events, Clinically significant changes in vital signs and laboratory parameters and 5 more. Planned start Sep 2026; status: authorised.